MétaCan
Menu
Back to cohort
Record W2125583020 · doi:10.1093/hmg/ddq291

Comprehensive analysis of common genetic variation in 61 genes related to steroid hormone and insulin-like growth factor-I metabolism and breast cancer risk in the NCI breast and prostate cancer cohort consortium†

2010· article· en· W2125583020 on OpenAlexaff
Federico Canzian, David G. Cox, Veronica Wendy Setiawan, Daniel O. Stram, Regina G. Ziegler, Laure Dossus, Lars Beckmann, Hélène Blanché, Aurelio Barricarte, Christine D. Berg, Sheila Bingham, Julie E. Buring, Saundra S. Buys, Eugenia E. Calle, Stephen J. Chanock, Françoise Clavel‐Chapelon, John Oliver DeLancey, W. Ryan Diver, Miren Dorronsoro, Christopher A. Haiman, Göran Hallmans, Susan E. Hankinson, David J. Hunter, Anika Hüsing, Claudine Isaacs, Kay‐Tee Khaw, Laurence N. Kolonel, Peter Kraft, Loı̈c Le Marchand, Eiliv Lund, Kim Overvad, Salvatore Panico, Petra H. Peeters, Michaël Pollak, Michael J. Thun, Anne Tjønneland, Dimitrios Trichopoulos, ­Rosario ­Tumino, Meredith Yeager, Robert N. Hoover, Elio Ríboli, Gilles Thomas, Brian E. Henderson, Rudolf Kaaks, Heather Spencer Feigelson

Bibliographic record

VenueHuman Molecular Genetics · 2010
Typearticle
Languageen
FieldMedicine
TopicCancer Risks and Factors
Canadian institutionsMcGill University
FundersNational Cancer InstituteNational Institutes of Health
KeywordsBiologyBreast cancerProstate cancerInternal medicineEndocrinologyOncologyHormoneSteroid hormoneCancerProstateRisk factorAndrogenInsulin-like growth factorMammary glandGrowth factorGeneticsMedicine

Abstract

fetched live from OpenAlex

There is extensive evidence that increases in blood and tissue concentrations of steroid hormones and of insulin-like growth factor I (IGF-I) are associated with breast cancer risk. However, studies of common variation in genes involved in steroid hormone and IGF-I metabolism have yet to provide convincing evidence that such variants predict breast cancer risk. The Breast and Prostate Cancer Cohort Consortium (BPC3) is a collaboration of large US and European cohorts. We genotyped 1416 tagging single nucleotide polymorphisms (SNPs) in 37 steroid hormone metabolism genes and 24 IGF-I pathway genes in 6292 cases of breast cancer and 8135 controls, mostly Caucasian, postmenopausal women from the BPC3. We also imputed 3921 additional SNPs in the regions of interest. None of the SNPs tested was significantly associated with breast cancer risk, after correction for multiple comparisons. The results remained null when cases and controls were stratified by age at diagnosis/recruitment, advanced or nonadvanced disease, body mass index, with or without in situ cases; or restricted to Caucasians. Among 770 estrogen receptor-negative cases, an SNP located 3' of growth hormone receptor (GHR) was marginally associated with increased risk after correction for multiple testing (P(trend) = 1.5 × 10(-4)). We found no significant overall associations between breast cancer and common germline variation in 61 genes involved in steroid hormone and IGF-I metabolism in this large, comprehensive study. Although previous studies have shown that variations in these genes can influence endogenous hormone levels, the magnitude of the effect of single SNPs does not appear to be sufficient to alter breast cancer risk.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.060
Threshold uncertainty score0.119

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0020.002
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0010.003
Science and technology studies0.0010.000
Scholarly communication0.0010.000
Open science0.0010.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.008
GPT teacher head0.269
Teacher spread0.261 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations47
Published2010
Admission routes1
Has abstractyes

Explore more

Same venueHuman Molecular GeneticsSame topicCancer Risks and FactorsFrench-language works237,207